Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 1999

View Archived Issues

Lexicon Genetics to provide knockout mice for BASF

Camptosar designated for priority review for new indication

New to the U.K. market: ophthalmic steroid from Alcon causes less IOP elevation

Infliximab now available in U.K. through Centocor licensee

Promising late-stage compounds discussed at Merck & Co. analyst meeting last week

ViroPharma and Wyeth-Ayerst form alliance to develop HCV drugs

Immune Response acquires T-cell receptor technology from Connetics and Xoma

Alliance's NDA for Imagent accepted for FDA review

Vasogen to commence clinical trials of VAS-981 for prevention of GVHD

Centaur comments on NXY-059 development

MGI Pharma commences phase I weekly dosing study with irofulven

Aventis finally becomes a reality

Novel inotropic agent EGIS-9377: potential advantages in the treatment of CHF

AstraZeneca files for new asthma combination product in Sweden

More on PTPase inhibitors in development at AHP

COX-2 inhibitor suggested to be active in squamous cell carcinoma

Antidiabetic thiazolidinediones under study at Taiho

Sordaricin derivatives with useful spectrum antifungal of activity

Pfizer investigates antipruritic activity of 4-phenylpiperidines

2,5-Pyridinedicarboxylic acid derivatives from Dong Wha inhibit retrovirus RT

Banyu tests improved successor to NB-506

SmithKline Beecham seeks approval of Factive in U.S.

Antiplatelet agents synthesized at Chinese university

Novel naturally occurring DNA polymerase beta inhibitor discovered at U. of Virginia

Novartis files NDA for extended-release formulation of fluvastatin

Paclimer Microspheres from Guilford progresses to human studies

Cathepsin C may be an important mediator in the development of periodontitis

Quark and Mitsubishi-Tokyo reach milestone in gene-based drug discovery collaboration

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...